Page last updated: 2024-08-25

epristeride and Prostatic Neoplasms

epristeride has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Audia, JE; Bruchovsky, N; Goode, RL; Hsiao, KC; Kaefer, M; Krushinski, JH; Lee, C; Leibovitch, IY; Neubauer, BL; Steidle, CP; Sutkowski, DM	1
Isaacs, JT; Johnson, RK; Lamb, JC; Levy, MA	1

Other Studies

2 other study(ies) available for epristeride and Prostatic Neoplasms

Article	Year
Characterization of type I 5 alpha-reductase activity in DU145 human prostatic adenocarcinoma cells. The Journal of steroid biochemistry and molecular biology, 1996, Volume: 58, Issue:2 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adenocarcinoma; Androstadienes; Benzoquinones; Cell Division; Enzyme Inhibitors; Finasteride; Gene Expression Regulation, Neoplastic; Humans; Isoenzymes; Male; Prostatic Neoplasms; RNA, Messenger; Selection, Genetic; Skin; Testosterone; Tumor Cells, Cultured	1996
Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657. The Prostate, 1992, Volume: 21, Issue:1 Topics: 5-alpha Reductase Inhibitors; Androstadienes; Animals; Antineoplastic Agents; Dihydrotestosterone; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Substrate Specificity; Tumor Cells, Cultured	1992

Article

Year

Characterization of type I 5 alpha-reductase activity in DU145 human prostatic adenocarcinoma cells.

The Journal of steroid biochemistry and molecular biology, 1996, Volume: 58, Issue:2

Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adenocarcinoma; Androstadienes; Benzoquinones; Cell Division; Enzyme Inhibitors; Finasteride; Gene Expression Regulation, Neoplastic; Humans; Isoenzymes; Male; Prostatic Neoplasms; RNA, Messenger; Selection, Genetic; Skin; Testosterone; Tumor Cells, Cultured

1996

Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657.

The Prostate, 1992, Volume: 21, Issue:1

Topics: 5-alpha Reductase Inhibitors; Androstadienes; Animals; Antineoplastic Agents; Dihydrotestosterone; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Substrate Specificity; Tumor Cells, Cultured

1992